„Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen

• Literatur

• 1 Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007; 11: 6-15
• 2 Von Ah D, Habermann B, Carpenter JS. et al Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs 2013; 17: 236-241 doi:10.1016/j. ejon.2012.06.002
• 3 Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995; 4: 61-66
• 4 Shilling V, Jenkins V, Trapala IS. The (mis)-classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 2006; 95: 125-129
• 5 Pomykala KL, de Ruiter MB, Deprez S. et al Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging Behav 2013; 7: 436-452 doi:10.1007/s11682-013-9239-y
• 6 Seigers R, Schagen SB, Van Tellingen O. et al Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav 2013; 7: 453-459 doi:10.1007/s11682-013-9250-3
• 7 Chung NC, Walker AK, Dhillon HM. et al Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies. Oncology (Williston Park) 2018; 32: 591-598
• 8 Ahles TA, Saykin AJ, McDonald BC. et al Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008; 110: 143-152
• 9 Hermelink K, Voigt V, Kaste J. et al Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst 2015; 107: djv099 doi:10.1093/jnci/djv099
• 10 Wefel JS, Lenzi R, Theriault R. et al ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 2004; 101: 466-475
• 11 Hermelink K, Untch M, Lux MP. et al Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007; 109: 1905-1913
• 12 Cimprich B, Reuter-Lorenz P, Nelson J. et al Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 2010; 32: 324-331 doi:10.1080/13803390903032537
• 13 Scherling C, Collins B, Mackenzie J. et al Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol 2012; 34: 543-560 doi:10.1080/13803395.2012.666227
• 14 Lopez Zunini RA, Scherling C, Wallis N. et al Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav 2013; 7: 460-477 doi:10.1007/s11682-012-9213-0
• 15 McDonald BC, Conroy SK, Ahles TA. et al Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 2012; 30: 2500-2508 doi:10.1200/JCO.2011.38.5674
• 16 Bernstein LJ, McCreath GA, Komeylian Z. et al Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neurosci Biobehav Rev 2017; 83: 417-428 doi:10.1016/j.neubiorev.2017.10.028
• 17 Ono M, Ogilvie JM, Wilson JS. et al A metaanalysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Front Oncol 2015; 5: 59 doi:10.3389/fonc.2015.00059
• 18 Vearncombe KJ, Rolfe M, Andrew B. et al Cognitive effects of chemotherapy-induced menopause in breast cancer. Clin Neuropsychol 2011; 25: 1295-1313 doi:10.1080/13854046.2011.631586
• 19 Hermelink K, Henschel V, Untch M. et al Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer 2008; 113: 2431-2439
• 20 Phillips KA, Regan MM, Ribi K. et al Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer 2016; 114: 956-964 doi:10.1038/bjc.2016.71
• 21 Van Dyk K, Crespi CM, Bower JE. et al The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment. Cancer 2019; 125: 681-689 doi:10.1002/cncr.31858
• 22 Underwood EA, Rochon PA, Moineddin R. et al Cognitive sequelae of endocrine therapy in women treated for breast cancer: a metaanalysis. Breast Cancer Res Treat 2018; 168: 299-310 doi:10.1007/s10549-017-4627-4
• 23 Ahles TA, Hurria A. New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions. Psycho-Oncology 2018; 27: 3-9 doi:10.1002/pon.4564
• 24 Andreotti C, Root JC, Ahles TA. et al Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline. Psycho-Oncology 2015; 24: 617-623 doi:10.1002/pon.3683
• 25 Bremner JD. Traumatic stress: effects on the brain. Dialogues Clin Neurosci 2006; 8: 445-461
• 26 Yang Y, Hendrix CC. Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables. Asia Pac J Oncol Nurs 2018; 5: 296-306 doi:10.4103/apjon.apjon_16_18
• 27 Hermelink K, Buhner M, Sckopke P. et al Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. J Natl Cancer Inst 2017; 109: djx057 doi:10.1093/jnci/djx057
• 28 Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv 2018; 12: 537-559 doi:10.1007/s11764-018-0692-x
• 29 Schagen SB, Das E, Vermeulen I. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psycho-Oncology 2012; 21: 1132-1135 doi:10.1002/pon.2011